IBT
FOMX

International Biotechnology Trust’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

International Biotechnology Trust’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-63,202
Closed -$324K – 65
2018
Q1 		$324K Sell
63,202
-319,636
-83% -$1.92M 0.13% 62
2017
Q4 		$2.3M Buy
+382,838
New +$2.3M 0.81% 35
2017
Q3 		– Sell
-358,975
Closed -$1.67M – 70
2017
Q2 		$1.67M Buy
358,975
+161,137
+81% +$719K 0.63% 41
2017
Q1 		$979K Hold
197,838
– – 0.37% 52
2016
Q4 		$2.2M Buy
+197,838
New +$1.86M 0.99% 21

Other funds holding FOMX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

International Biotechnology Trust's FOMX Position: Q2 2018 in Review

International Biotechnology Trust sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2018, closing a stake of 63,202 shares — an estimated $324K sold.

International Biotechnology Trust first reported a position in FOMX in Q4 2016 and held it in 5 quarters. The position peaked at $2.3M in Q4 2017. 56 funds tracked by Wall St. Rank hold FOMX as of Q2 2018.

  • International Biotechnology Trust reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 63,202 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2018, an estimated $324K.
  • International Biotechnology Trust first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2016 and held it in 5 quarters.
  • International Biotechnology Trust's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $2.3M in Q4 2017.
  • 56 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2018.

Based on International Biotechnology Trust's 13F filing for Q2 2018, filed 13 Aug 2018.